Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Experimental Cell Research

• Publication date

  2009-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.yexcr.2009.06.024PMID 19563799
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The molecular determinants of de novo nucleotide biosynthesis in cancer cells.

  2009cited by this paper
• Targeting the RAF-MEK-ERK pathway in cancer therapy.

  2009cited by this paper
• Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis.

  2009cited by this paper
• Pyruvate kinase M2 is a phosphotyrosine-binding protein

  2008cited by this paper
• Isotype‐specific inhibitors of the glycolytic key regulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation

  2008cited by this paper
• The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.

  2008cited by this paper
• L-Xylulose reductase is involved in 9,10-phenanthrenequinone-induced apoptosis in human T lymphoma cells.

  2008cited by this paper
• The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

  2008cited by this paper
• SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell Growth

  2008cited by this paper
• The interplay between MYC and HIF in cancer

  2008cited by this paper
• Regulation of pyruvate kinase type M2 by A-Raf: a possible glycolytic stop or go mechanism.

  2007cited by this paper
• Cellular redox state predicts in vitro corneal endothelial cell proliferation capacity.

  2006cited by this paper
• Pyruvate kinase type M2 and its role in tumor growth and spreading.

  2005cited by this paper
• Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development

  2005cited by this paper
• The Solution Structure of the FATC Domain of the Protein Kinase Target of Rapamycin Suggests a Role for Redox-dependent Structural and Cellular Stability*

  2005cited by this paper
• K-ras codon-specific mutations produce distinctive metabolic phenotypes in NIH3T3 mice [corrected] fibroblasts.

  2005cited by this paper
• Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death.

  2005cited by this paper
• Akt-dependent transformation: there is more to growth than just surviving

  2005cited by this paper
• Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements

  2005cited by this paper
• Redox Regulation of the Nutrient-sensitive Raptor-mTOR Pathway and Complex*

  2005cited by this paper
• K-ras Codon-Specific Mutations Produce Distinctive Metabolic Phenotypes in Human Fibroblasts

  2005cited by this paper
• Evaluation of Myc E-Box Phylogenetic Footprints in Glycolytic Genes by Chromatin Immunoprecipitation Assays

  2004cited by this paper
• TOR signaling in yeast : temporal and spatial control of cell growth

  2004cited by this paper
• Cell growth : control of cell size

  2004cited by this paper
• Beginnings of a signal-transduction pathway for bioenergetic control of cell survival.

  2004cited by this paper
• Why do cancers have high aerobic glycolysis?

  2004cited by this paper
• Decreased pyruvate kinase M2 activity linked to cisplatin resistance in human gastric carcinoma cell lines

  2004cited by this paper
• Energy Substrate Modulates Mitochondrial Structure and Oxidative Capacity in Cancer Cells

  2004cited by this paper
• Antiangiogenic and Proapoptotic Effects of Dietary Restriction on Experimental Mouse and Human Brain Tumors

  2004cited by this paper
• 7 Growth Control through the mTOR Network

  2004cited by this paper
• Inhibition of Glucose Metabolism Sensitizes Tumor Cells to Death Receptor-triggered Apoptosis through Enhancement of Death-inducing Signaling Complex Formation and Apical Procaspase-8 Processing*

  2003cited by this paper
• Hypoxia-inducible Factor-1-mediated Expression of the 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) Gene

  2002cited by this paper
• Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake.

  2002cited by this paper
• Metabolic mapping with bioluminescence: basic and clinical relevance.

  2002cited by this paper
• Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7

  2001cited by this paper
• Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic-enzyme complex.

  2001cited by this paper
• Akt and Bcl-xL Promote Growth Factor-independent Survival through Distinct Effects on Mitochondrial Physiology*

  2001cited by this paper
• Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase.

  2001cited by this paper
• Cell transformation by the E7 oncoprotein of human papillomavirus type 16: interactions with nuclear and cytoplasmic target proteins.

  2000cited by this paper
• Insulin Receptor Substrate-1, p70S6K, and Cell Size in Transformation and Differentiation of Hemopoietic Cells*

  2000cited by this paper
• Oncogenic alterations of metabolism.

  1999cited by this paper
• Importance of glucose-6-phosphate dehydrogenase activity in cell death.

  1999cited by this paper
• Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.

  1999cited by this paper
• Importance of glucose-6-phosphate dehydrogenase activity in cell death.

  1999cited by this paper
• An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect.

  1999cited by this paper
• Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

  1998cited by this paper
• Importance of Glucose-6-phosphate Dehydrogenase Activity for Cell Growth*

  1998cited by this paper
• A unique glucose-dependent apoptotic pathway induced by c-Myc.

  1998cited by this paper
• Methods for studying cell death and viability in primary neuronal cultures.

  1995cited by this paper
• Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1.

  1994cited by this paper
• Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction.

  1993cited by this paper
• Regulation of 6-phosphofructo-1-kinase activity in ras-transformed rat-1 fibroblasts.

  1991cited by this paper
• The Retardation of Aging and Disease by Dietary Restriction

  1988cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.

  1979cited by this paper
• Glycolytic enzyme activities in murine sarcoma virus-transformed cultures of Balb 3T3. The role of culture density.

  1976cited by this paper
• [Origin of cancer cells].

  1956cited by this paper
• On the origin of cancer cells.

  1956cited by this paper
• THE INFLUENCE OF DIET ON TRANSPLANTED AND SPONTANEOUS MOUSE TUMORS

  1914cited by this paper

• Gene Expression of Glycolysis Enzymes in MCF-7 Breast Cancer Cells Exposed to Warburg Effect and Hypoxia

  2024cites this paper
• The PKM2 inhibitor shikonin enhances piceatannol‐induced apoptosis of glyoxalase I‐dependent cancer cells

  2023cites this paper
• PKM2 Nuclear Translocation Promotes Glial Cell Activation and Aggravates the Brain Injury of Intracerebral Hemorrhage.

  2023cites this paper
• The Role of Reprogrammed Glucose Metabolism in Cancer

  2023cites this paper
• Interplay between Mitochondrial Metabolism and Cellular Redox State Dictates Cancer Cell Survival

  2021cites this paper
• Investigation of glucose catabolism in hypoxic Mcf 7 breast cancer culture

  2021cites this paper
• Specific Pyruvate Kinase M2 Inhibitor, Compound 3K, Induces Autophagic Cell Death through Disruption of the Glycolysis Pathway in Ovarian Cancer Cells

  2021cites this paper
• Molecular interactions of miR-338 during tumor progression and metastasis

  2021cites this paper
• Compound 3K, a Specific Pyruvate Kinase M2 Inhibitor, Induces Autophagic Cell Death through the Disruption of the Glycolytic Pathway in Ovarian Cancer Cells

  2020cites this paper
• Enhanced patterns on intraoperative contrast-enhanced ultrasonography predict outcomes after curative liver resection in patients with hepatocellular carcinoma

  2020cites this paper
• Suppressed “Warburg Effect” in Nasopharyngeal Carcinoma Via the Inhibition of Pyruvate Kinase Type M2-Mediated Energy Generation Pathway

  2020cites this paper
• Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting Tumorigenesis

  2020cites this paper
• Biochemical and structural insights into how amino acids regulate pyruvate kinase muscle isoform 2

  2020cites this paper
• LncRNA RPPH1 attenuates Aβ25-35-induced endoplasmic reticulum stress and apoptosis in SH-SY5Y cells via miR-326/PKM2

  2020cites this paper
• Low-dose 2-deoxy glucose stabilises tolerogenic dendritic cells and generates potent in vivo immunosuppressive effects

  2020cites this paper
• Structural basis for allosteric regulation of pyruvate kinase M2 by phosphorylation and acetylation.

  2020cites this paper
• TRAF4 acts as a fate checkpoint to regulate the adipogenic differentiation of MSCs by activating PKM2

  2020cites this paper
• PKM2, function and expression and regulation

  2019cites this paper
• PKM2 enhances cancer invasion via ETS-1-dependent induction of matrix metalloproteinase in oral squamous cell carcinoma cells

  2019cites this paper
• The role of pyruvate kinase M2 in anticancer therapeutic treatments

  2019cites this paper
• PKM2 knockdown influences SREBP activation and lipid synthesis in bovine mammary-gland epithelial MAC-T cells

  2018cites this paper
• Metformin reverses established lung fibrosis in a bleomycin model

  2018cites this paper
• Knockdown of pyruvate kinase type M2 suppresses tumor survival and invasion in osteosarcoma cells both in vitro and in vivo

  2018cites this paper
• Non-coding RNAs in the reprogramming of glucose metabolism in cancer.

  2018cites this paper
• Apigenin Restrains Colon Cancer Cell Proliferation via Targeted Blocking of Pyruvate Kinase M2-Dependent Glycolysis.

  2017cites this paper
• Analysis of A549 cell proteome alteration in response to recombinant influenza A virus nucleoprotein and its interaction with cellular proteins, a preliminary study.

  2017cites this paper
• Manipulating aktivated metabolism via mtorc 1 2013

  2017cites this paper
• Non‐Metabolic Role of PKM2 in Regulation of the HIV‐1 LTR

  2017cites this paper
• Berberine Inhibited the Proliferation of Cancer Cells by Suppressing the Activity of Tumor Pyruvate Kinase M2

  2017cites this paper
• Plasma TuM2-PK correlates with tumor size, CRP and CA 15-3 in metastatic breast carcinomas; short versus long term follow up study of the Egyptian breast cancer patients

  2017cites this paper
• Epigenetic silencing of miR-338 facilitates glioblastoma progression by de-repressing the pyruvate kinase M2-β-catenin axis

  2017cites this paper
• Chaperone-mediated autophagy substrate proteins in cancer

  2017cites this paper
• PKM2 and cancer: The function of PKM2 beyond glycolysis

  2016cites this paper
• Pyruvate Kinase M2 (PKM2) and Lactate Dehydrogenase A (LDHA) as Novel Diagnostic Markers and Therapeutic Targets for Pancreatic Cancer

  2016influential citation
• Pyruvate Kinase M2 and Lactate Dehydrogenase A Are Overexpressed in Pancreatic Cancer and Correlate with Poor Outcome

  2016cites this paper
• General intelligence is associated with subclinical inflammation in Nepalese children: A population-based plasma proteomics study

  2016cites this paper
• Modulation of GLO1 Expression Affects Malignant Properties of Cells

  2016cites this paper
• Genetic Evidence For Neuron-Glia Metabolic Coupling In The CNS

  2016influential citation
• Pantoprazole inhibits human gastric adenocarcinoma SGC-7901 cells by downregulating the expression of pyruvate kinase M2.

  2016cites this paper
• Intra-uterine undernutrition amplifies age-associated glucose intolerance in pigs via altered DNA methylation at muscle GLUT4 promoter

  2016cites this paper
• In vitro effects of some flavonoids and phenolic acids on human pyruvate kinase isoenzyme M2

  2016cites this paper
• Knockdown of PKM2 induces apoptosis and autophagy in human A549 alveolar adenocarcinoma cells.

  2015cites this paper
• Integrating Proteomics and Enzyme Kinetics Reveals Tissue-Specific Types of the Glycolytic and Gluconeogenic Pathways.

  2015cites this paper
• Isoform Switch of Pyruvate Kinase M1 Indeed Occurs but Not to Pyruvate Kinase M2 in Human Tumorigenesis

  2015cites this paper
• Expression and immunological characteristics of the surface-localized pyruvate kinase in Mycoplasma gallisepticum.

  2015cites this paper
• Cancer‐like metabolism of the mammalian retina

  2015cites this paper
• Enzymes of the central carbon metabolism: are they linkers between transcription, DNA replication, and carcinogenesis?

  2015cites this paper
• Pyruvate kinase isoform M2 (PKM2) participates in multiple myeloma cell proliferation, adhesion and chemoresistance.

  2015cites this paper
• Micro-scale strategy to detect spermine and spermidine by MALDI-TOF MS in foods and identification of apoptosis-related proteins by nano-flow UPLC-MS/MS after treatment with spermine and spermidine.

  2015cites this paper
• Pyruvate kinase isoenzyme M2 expression correlates with survival of cardiomyocytes after allogeneic rat heterotopic heart transplantation.

  2015cites this paper
• Pyruvate Kinase M2: A Metabolic Tuner

  2015cites this paper
• ERK2-Pyruvate Kinase Axis Permits Phorbol 12-Myristate 13-Acetate-induced Megakaryocyte Differentiation in K562 Cells*

  2015cites this paper
• Activators of PKM2 in cancer metabolism.

  2014cites this paper
• PKM2 regulates hepatocellular carcinoma cell epithelial-mesenchymal transition and migration upon EGFR activation.

  2014cites this paper
• The multifaceted regulation and functions of PKM2 in tumor progression.

  2014cites this paper
• Glioma Stem Cells: The Brain Behind the Tumor?

  2014cites this paper
• Pyruvate kinase M2 and cancer: an updated assessment

  2014cites this paper
• Pyruvate kinase M2: regulatory circuits and potential for therapeutic intervention.

  2014cites this paper
• Inhibition of tumour cell growth by carnosine: some possible mechanisms

  2014influential citation
• Anchorless 23–230 PrPC Interactomics for Elucidation of PrPC Protective Role

  2014cites this paper
• Protective role of the mitochondrial Lon protease 1 in ochratoxin A-induced cytotoxicity in HEK293 cells.

  2014influential citation
• Regulation of Pyruvate Kinase M2 (PKM2) Expression and Activity in Cardiac Hypertrophy

  2013cites this paper
• Sensor potency of the moonlighting enzyme-decorated cytoskeleton: the cytoskeleton as a metabolic sensor

  2013cites this paper
• Pyruvate kinase M2 is highly correlated with the differentiation and the prognosis of esophageal squamous cell cancer.

  2013cites this paper
• Development and characterization of aptamer-amphiphiles against fractalkine for targeted drug delivery

  2013cites this paper
• Anticancer Agent Shikonin Is an Incompetent Inducer of Cancer Drug Resistance

  2013cites this paper
• Targeting Metabolism to Induce Cell Death in Cancer Cells and Cancer Stem Cells

  2013cites this paper
• Cancer metabolism meets systems biology: Pyruvate kinase isoform PKM2 is a metabolic master regulator

  2013cites this paper
• Manipulating aktivated metabolism via mtorc1

  2013cites this paper
• Targeting glucose metabolism for cancer therapy

  2012cites this paper
• Pyruvate Kinase M2: Multiple Faces for Conferring Benefits on Cancer Cells

  2012cites this paper
• Vitamin K(3) and K(5) are inhibitors of tumor pyruvate kinase M2.

  2012cites this paper
• Proteomic analysis of hepatitis C virus (HCV) core protein transfection and host regulator PA28γ knockout in HCV pathogenesis: a network-based study.

  2012cites this paper
• Use of ESAT-6-CFP-10 fusion protein in the bovine interferon-gamma ELISPOT assay for diagnosis of Mycobacterium bovis infection in cattle.

  2012cites this paper
• Exploratory Data Analysis using Clusters and Stories

  2012cites this paper
• Exercise Does Not Protect against MPTP-Induced Neurotoxicity in BDNF Happloinsufficent Mice

  2012cites this paper
• Pyruvate kinase type M2 is upregulated in colorectal cancer and promotes proliferation and migration of colon cancer cells

  2012cites this paper
• Investigation of mammalian cell metabolism by quantification of key metabolic enzyme activities

  2012cites this paper
• Pyruvate kinase M2: A key enzyme of the tumor metabolome and its medical relevance.

  2012cites this paper
• Characterization of SMAD3 function in skeletal muscle growth.

  2012cites this paper
• Connecting the Dots between PubMed Abstracts

  2012cites this paper
• Biosignatures for Parkinson’s Disease and Atypical Parkinsonian Disorders Patients

  2012cites this paper
• Altered Hypothalamic Protein Expression in a Rat Model of Huntington's Disease

  2012cites this paper
• Death-associated proliferation kinetic in normal and transformed cells

  2012cites this paper
• SAICAR Stimulates Pyruvate Kinase Isoform M2 and Promotes Cancer Cell Survival in Glucose-Limited Conditions

  2012cites this paper
• Anticancer Agents That Counteract Tumor Glycolysis

  2012cites this paper
• Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth

  2011cites this paper
• Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis.

  2011cites this paper
• Antitumor Effect of Honey and Squirting Cucumber Fruit Juice Mixture on Glioblastoma Cells in Vitro

  2011cites this paper
• Biogerontology in Austria

  2011cites this paper
• Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.

  2011cites this paper
• Differential Proteome Analysis of Bone Marrow Mesenchymal Stem Cells from Adolescent Idiopathic Scoliosis Patients

  2011cites this paper
• Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2

  2011cites this paper
• Emerging metabolic targets in cancer therapy.

  2011cites this paper
• No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis

  2011cites this paper
• Identification of Novel Molecular Targets for Endometrial Cancer Using a Drill-Down LC-MS/MS Approach with iTRAQ

  2011cites this paper
• Identification of small molecule inhibitors of pyruvate kinase M2.

  2010cites this paper
• A proteomic study of cMyc improvement of CHO culture

  2010cites this paper
• Human pyruvate kinase M2: A multifunctional protein

  2010cites this paper
• Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice

  2010cites this paper